Repository logo
 

Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.

Published version
Peer-reviewed

Change log

Authors

Kehrloesser, Sebastian 
Westerhuis, Willien 
Wendler, Astrid 
Wind, Anke 

Abstract

There is a persistent variation in cancer outcomes among and within European countries suggesting (among other causes) inequalities in access to or delivery of high-quality cancer care. European policy (EU Cancer Mission and Europe's Beating Cancer Plan) is currently moving towards a mission-oriented approach addressing these inequalities. In this study, we used the quantitative and qualitative data of the Organisation of European Cancer Institutes' Accreditation and Designation Programme, relating to 40 large European cancer centres, to describe their current compliance with quality standards, to identify the hallmarks common to all centres and to show the distinctive features of Comprehensive Cancer Centres. All Comprehensive Cancer Centres and Cancer Centres accredited by the Organisation of European Cancer Institutes show good compliance with quality standards related to care, multidisciplinarity and patient centredness. However, Comprehensive Cancer Centres on average showed significantly better scores on indicators related to the volume, quality and integration of translational research, such as high-impact publications, clinical trial activity (especially in phase I and phase IIa trials) and filing more patents as early indicators of innovation. However, irrespective of their size, centres show significant variability regarding effective governance when functioning as entities within larger hospitals.

Description

Keywords

accreditation, clinical trials, comprehensive cancer center, multidisciplinarity, quality standard, translational research, Academies and Institutes, Biomedical Research, Cancer Care Facilities, Cohort Studies, Europe, Humans, Medical Oncology, Neoplasms, Patient Care Team, Patient-Centered Care, Quality of Health Care, Translational Research, Biomedical

Journal Title

Mol Oncol

Conference Name

Journal ISSN

1574-7891
1878-0261

Volume Title

15

Publisher

Wiley
Sponsorship
Intuitive Surgical (N/A)
Agendia BV (N/A)
Organisation of European Cancer Institutes (N/A)
Novartis (N/A)
Hungarian Thematic Excellence Programme ((TKP2020‐NKA‐26))